{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:24:38Z","timestamp":1792621478678,"version":"4.5.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s40618-016-0447-3","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T03:09:48Z","timestamp":1458529788000},"page":"595-606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Update on parathyroid carcinoma"],"prefix":"10.1007","volume":"39","author":[{"given":"F.","family":"Cetani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"issue":"12","key":"447_CR1","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1359\/jbmr.081018","volume":"23","author":"C Marcocci","year":"2008","unstructured":"Marcocci C, Cetani F, Rubin MR, Silverberg SJ, Pinchera A, Bilezikian JP (2008) Parathyroid carcinoma. J Bone Miner Res 23(12):1869\u20131880","journal-title":"J Bone Miner Res"},{"key":"447_CR2","doi-asserted-by":"crossref","unstructured":"Cetani F, Marcocci C (2015) Parathyroid carcinoma. In: Bilezikian JP, Marcus R, Levine MA, Marcocci C, Silverberg SJ, J.T. PJ (eds) The parathyroids. Basic and Clinical concepts. vol 1. 3rd edn. Elsevier, Waltham. pp 409\u2013421","DOI":"10.1016\/B978-0-12-397166-1.00027-8"},{"issue":"2","key":"447_CR3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12105-009-0115-4","volume":"3","author":"BJ Wilkins","year":"2009","unstructured":"Wilkins BJ, Lewis JS Jr (2009) Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery. Head Neck Pathol 3(2):140\u2013149. doi: 10.1007\/s12105-009-0115-4","journal-title":"Head Neck Pathol"},{"issue":"12","key":"447_CR4","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","volume":"96","author":"A Harari","year":"2011","unstructured":"Harari A, Waring A, Fernandez-Ranvier G, Hwang J, Suh I, Mitmaker E, Shen W, Gosnell J, Duh QY, Clark O (2011) Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab 96(12):3679\u20133686","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"447_CR5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4158\/EP.13.7.750","volume":"13","author":"GG Fernandez-Ranvier","year":"2007","unstructured":"Fernandez-Ranvier GG, Jensen K, Khanafshar E, Quivey JM, Glastonbury C, Kebebew E, Duh QY, Clark OH (2007) Nonfunctioning parathyroid carcinoma: case report and review of literature. Endocr Pract 13(7):750\u2013757 (T813482448232M1H [pii])","journal-title":"Endocr Pract"},{"key":"447_CR6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12957-015-0672-9","volume":"13","author":"F Cetani","year":"2015","unstructured":"Cetani F, Frustaci G, Torregrossa L, Magno S, Basolo F, Campomori A, Miccoli P, Marcocci C (2015) A nonfunctioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule. World J Surg Oncol 13:270. doi: 10.1186\/s12957-015-0672-9","journal-title":"World J Surg Oncol"},{"issue":"1","key":"447_CR7","first-page":"100","volume":"25","author":"NH Boyle","year":"1999","unstructured":"Boyle NH, Ogg CS, Hartley RB, Owen WJ (1999) Parathyroid carcinoma secondary to prolonged hyperplasia in chronic renal failure and in coeliac disease. Eur J Surg Oncol 25(1):100\u2013103","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"447_CR8","doi-asserted-by":"crossref","first-page":"E1108","DOI":"10.1210\/jc.2011-0099","volume":"96","author":"M Fallah","year":"2011","unstructured":"Fallah M, Kharazmi E, Sundquist J, Hemminki K (2011) Nonendocrine cancers associated with benign and malignant parathyroid tumors. J Clin Endocrinol Metab 96(7):E1108\u2013E1114. doi: 10.1210\/jc.2011-0099","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"447_CR9","first-page":"N37","volume":"17","author":"SJ Marx","year":"2002","unstructured":"Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, Skarulis MC, Spiegel AM, Libutti SK, Alexander HR Jr, Chen CC, Chang R, Chandrasekharappa SC, Collins FS (2002) Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 17(Suppl 2):N37\u2013N43","journal-title":"J Bone Miner Res"},{"issue":"3","key":"447_CR10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","volume":"31","author":"PJ Newey","year":"2010","unstructured":"Newey PJ, Bowl MR, Cranston T, Thakker RV (2010) Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Hum Mutat 31(3):295\u2013307","journal-title":"Hum Mutat"},{"issue":"1","key":"447_CR11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","volume":"257","author":"KJ Bradley","year":"2005","unstructured":"Bradley KJ, Hobbs MR, Buley ID, Carpten JD, Cavaco BM, Fares JE, Laidler P, Manek S, Robbins CM, Salti IS, Thompson NW, Jackson CE, Thakker RV (2005) Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med 257(1):18\u201326. doi: 10.1111\/j.1365-2796.2004.01421.x","journal-title":"J Intern Med"},{"issue":"6","key":"447_CR12","first-page":"1485","volume":"77","author":"WS Wassif","year":"1993","unstructured":"Wassif WS, Moniz CF, Friedman E, Wong S, Weber G, Nordenskjold M, Peters TJ, Larsson C (1993) Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab 77(6):1485\u20131489","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"447_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","volume":"81","author":"WF Simonds","year":"2002","unstructured":"Simonds WF, James-Newton LA, Agarwal SK, Yang B, Skarulis MC, Hendy GN, Marx SJ (2002) Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81(1):1\u201326","journal-title":"Medicine (Baltimore)"},{"key":"447_CR14","doi-asserted-by":"crossref","unstructured":"del Pozo C, Garcia-Pascual L, Balsells M, Barahona MJ, Veloso E, Gonzalez C, Anglada-Barcelo J (2011) Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature. Hormones (Athens) 10(4):326\u2013331","DOI":"10.14310\/horm.2002.1325"},{"issue":"6","key":"447_CR15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2265.1997.3421147.x","volume":"47","author":"PJ Jenkins","year":"1997","unstructured":"Jenkins PJ, Satta MA, Simmgen M, Drake WM, Williamson C, Lowe DG, Britton K, Chew SL, Thakker RV, Besser GM (1997) Metastatic parathyroid carcinoma in the MEN2A syndrome. Clin Endocrinol 47(6):747\u2013751","journal-title":"Clin Endocrinol"},{"issue":"7 Suppl","key":"447_CR16","first-page":"35","volume":"34","author":"F Cetani","year":"2011","unstructured":"Cetani F, Pardi E, Borsari S, Marcocci C (2011) Molecular pathogenesis of primary hyperparathyroidism. J Endocrinol Invest 34(7 Suppl):35\u201339 (8004 [pii])","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"447_CR17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath H 3rd, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32(4):676\u2013680","journal-title":"Nat Genet"},{"issue":"9","key":"447_CR18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40(9):657\u2013663","journal-title":"J Med Genet"},{"issue":"11","key":"447_CR19","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","volume":"89","author":"F Cetani","year":"2004","unstructured":"Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L, Ambrogini E, Gazzerro E, Colussi G, Berti P, Miccoli P, Pinchera A, Marcocci C (2004) Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89(11):5583\u20135591","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"447_CR20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jc.2003-030675","volume":"89","author":"WF Simonds","year":"2004","unstructured":"Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ (2004) Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89(1):96\u2013102","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"447_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jmg.2003.016725","volume":"41","author":"J Warner","year":"2004","unstructured":"Warner J, Epstein M, Sweet A, Singh D, Burgess J, Stranks S, Hill P, Perry-Keene D, Learoyd D, Robinson B, Birdsey P, Mackenzie E, Teh BT, Prins JB, Cardinal J (2004) Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 41(3):155\u2013160","journal-title":"J Med Genet"},{"issue":"3","key":"447_CR22","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1136\/jmg.2003.012369","volume":"41","author":"A Villablanca","year":"2004","unstructured":"Villablanca A, Calender A, Forsberg L, Hoog A, Cheng JD, Petillo D, Bauters C, Kahnoski K, Ebeling T, Salmela P, Richardson AL, Delbridge L, Meyrier A, Proye C, Carpten JD, Teh BT, Robinson BG, Larsson C (2004) Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet 41(3):e32","journal-title":"J Med Genet"},{"issue":"3","key":"447_CR23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2006.02460.x","volume":"64","author":"KJ Bradley","year":"2006","unstructured":"Bradley KJ, Cavaco BM, Bowl MR, Harding B, Cranston T, Fratter C, Besser GM, Conceicao Pereira M, Davie MW, Dudley N, Leite V, Sadler GP, Seller A, Thakker RV (2006) Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin Endocrinol 64(3):299\u2013306. doi: 10.1111\/j.1365-2265.2006.02460.x","journal-title":"Clin Endocrinol"},{"issue":"1","key":"447_CR24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2006.02534.x","volume":"65","author":"N Mizusawa","year":"2006","unstructured":"Mizusawa N, Uchino S, Iwata T, Tsuyuguchi M, Suzuki Y, Mizukoshi T, Yamashita Y, Sakurai A, Suzuki S, Beniko M, Tahara H, Fujisawa M, Kamata N, Fujisawa K, Yashiro T, Nagao D, Golam HM, Sano T, Noguchi S, Yoshimoto K (2006) Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome. Clin Endocrinol 65(1):9\u201316. doi: 10.1111\/j.1365-2265.2006.02534.x","journal-title":"Clin Endocrinol"},{"issue":"8","key":"447_CR25","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/jc.2005-1239","volume":"91","author":"V Guarnieri","year":"2006","unstructured":"Guarnieri V, Scillitani A, Muscarella LA, Battista C, Bonfitto N, Bisceglia M, Minisola S, Mascia ML, D\u2019Agruma L, Cole DE (2006) Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance. J Clin Endocrinol Metab 91(8):2827\u20132832. doi: 10.1210\/jc.2005-1239","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"447_CR26","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1359\/jbmr.060702","volume":"21","author":"TG Kelly","year":"2006","unstructured":"Kelly TG, Shattuck TM, Reyes-Mugica M, Stewart AF, Simonds WF, Udelsman R, Arnold A, Carpenter TO (2006) Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res 21(10):1666\u20131671. doi: 10.1359\/jbmr.060702","journal-title":"J Bone Miner Res"},{"issue":"9","key":"447_CR27","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1210\/jc.2014-1481","volume":"99","author":"E Korpi-Hyovalti","year":"2014","unstructured":"Korpi-Hyovalti E, Cranston T, Ryhanen E, Arola J, Aittomaki K, Sane T, Thakker RV, Schalin-Jantti C (2014) CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma. J Clin Endocrinol Metab 99(9):3044\u20133048. doi: 10.1210\/jc.2014-1481","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"447_CR28","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349(18):1722\u20131729","journal-title":"N Engl J Med"},{"issue":"5","key":"447_CR29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"Cetani F, Ambrogini E, Viacava P, Pardi E, Fanelli G, Naccarato AG, Borsari S, Lemmi M, Berti P, Miccoli P, Pinchera A, Marcocci C (2007) Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol\/Eur Feder Endocrine Soc 156(5):547\u2013554","journal-title":"Eur J Endocrinol\/Eur Feder Endocrine Soc"},{"issue":"3","key":"447_CR30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2265.2007.02894.x","volume":"67","author":"CJ Haven","year":"2007","unstructured":"Haven CJ, van Puijenbroek M, Tan MH, Teh BT, Fleuren GJ, van Wezel T, Morreau H (2007) Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas. Clin Endocrinol 67(3):370\u2013376","journal-title":"Clin Endocrinol"},{"issue":"10","key":"447_CR31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/BF03346439","volume":"31","author":"F Cetani","year":"2008","unstructured":"Cetani F, Pardi E, Ambrogini E, Banti C, Viacava P, Borsari S, Bilezikian JP, Pinchera A, Marcocci C (2008) Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment. J Endocrinol Invest 31(10):900\u2013904 (5015 [pii])","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"447_CR32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","volume":"35","author":"V Guarnieri","year":"2012","unstructured":"Guarnieri V, Battista C, Muscarella LA, Bisceglia M, de Martino D, Baorda F, Maiello E, D\u2019Agruma L, Chiodini I, Clemente C, Minisola S, Romagnoli E, Corbetta S, Viti R, Eller-Vainicher C, Spada A, Iacobellis M, Malavolta N, Carella M, Canaff L, Hendy GN, Cole DE, Scillitani A (2012) CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort. Cell Oncol (Dordr) 35(6):411\u2013422","journal-title":"Cell Oncol (Dordr)"},{"issue":"9","key":"447_CR33","doi-asserted-by":"crossref","first-page":"e45567","DOI":"10.1371\/journal.pone.0045567","volume":"7","author":"O Wang","year":"2012","unstructured":"Wang O, Wang C, Nie M, Cui Q, Guan H, Jiang Y, Li M, Xia W, Meng X, Xing X (2012) Novel HRPT2\/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas. PLoS One 7(9):e45567","journal-title":"PLoS One"},{"issue":"2","key":"447_CR34","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","volume":"98","author":"L Bricaire","year":"2013","unstructured":"Bricaire L, Odou MF, Cardot-Bauters C, Delemer B, North MO, Salenave S, Vezzosi D, Kuhn JM, Murat A, Caron P, Sadoul JL, Silve C, Chanson P, Barlier A, Clauser E, Porchet N, Groussin L (2013) Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. J Clin Endocrinol Metab 98(2):E403\u2013E408","journal-title":"J Clin Endocrinol Metab"},{"key":"447_CR35","doi-asserted-by":"crossref","unstructured":"Cetani F, Banti C, Pardi E, Borsari S, Viacava P, Miccoli P, Torregrossa L, Basolo F, Pelizzo MR, Rugge M, Pennelli G, Gasparri G, Papotti M, Volante M, Vignali E, Saponaro F, Marcocci C (2013) CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. Endocr Connect 2(4):186\u2013195. doi: 10.1530\/EC-13-0046","DOI":"10.1530\/EC-13-0046"},{"issue":"2","key":"447_CR36","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2014-3238","volume":"100","author":"W Yu","year":"2015","unstructured":"Yu W, McPherson JR, Stevenson M, van Eijk R, Heng HL, Newey P, Gan A, Ruano D, Huang D, Poon SL, Ong CK, van Wezel T, Cavaco B, Rozen SG, Tan P, Teh BT, Thakker RV, Morreau H (2015) Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J Clin Endocrinol Metab 100(2):E360\u2013E364. doi: 10.1210\/jc.2014-3238","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"447_CR37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12022-011-9151-1","volume":"22","author":"BM Cavaco","year":"2011","unstructured":"Cavaco BM, Santos R, Felix A, Carvalho D, Lopes JM, Domingues R, Sirgado M, Rei N, Fonseca F, Santos JR, Sobrinho L, Leite V (2011) Identification of de novo germline mutations in the HRPT2 gene in two apparently sporadic cases with challenging parathyroid tumor diagnoses. Endocrine Pathol 22(1):44\u201352. doi: 10.1007\/s12022-011-9151-1","journal-title":"Endocrine Pathol"},{"issue":"1","key":"447_CR38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.2011.04184.x","volume":"76","author":"R Domingues","year":"2012","unstructured":"Domingues R, Tomaz RA, Martins C, Nunes C, Bugalho MJ, Cavaco BM (2012) Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism. Clin Endocrinol 76(1):33\u201338. doi: 10.1111\/j.1365-2265.2011.04184.x","journal-title":"Clin Endocrinol"},{"issue":"11","key":"447_CR39","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1007\/s00268-010-0618-x","volume":"34","author":"K Enomoto","year":"2010","unstructured":"Enomoto K, Uchino S, Ito A, Watanabe S, Shibuya H, Enomoto Y, Noguchi S (2010) The surgical strategy and the molecular analysis of patients with parathyroid cancer. World J Surg 34(11):2604\u20132610. doi: 10.1007\/s00268-010-0618-x","journal-title":"World J Surg"},{"issue":"4","key":"447_CR40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10689-011-9466-6","volume":"10","author":"WK Siu","year":"2011","unstructured":"Siu WK, Law CY, Lam CW, Mak CM, Wong GW, Ho AY, Ho KY, Loo KT, Chiu SC, Chow LT, Tong SF, Chan AY (2011) Novel nonsense CDC73 mutations in Chinese patients with parathyroid tumors. Fam Cancer 10(4):695\u2013699. doi: 10.1007\/s10689-011-9466-6","journal-title":"Fam Cancer"},{"issue":"12","key":"447_CR41","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/000348940711601210","volume":"116","author":"KM Hewitt","year":"2007","unstructured":"Hewitt KM, Sharma PK, Samowitz W, Hobbs M (2007) Aberrant methylation of the HRPT2 gene in parathyroid carcinoma. Ann Otol Rhinol Laryngol 116(12):928\u2013933","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"9","key":"447_CR42","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1210\/jc.2005-0717","volume":"90","author":"LJ Krebs","year":"2005","unstructured":"Krebs LJ, Shattuck TM, Arnold A (2005) HRPT2 mutational analysis of typical sporadic parathyroid adenomas. J Clin Endocrinol Metab 90(9):5015\u20135017","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"447_CR43","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1128\/MCB.25.12.5052-5060.2005","volume":"25","author":"A Yart","year":"2005","unstructured":"Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D, Krek W (2005) The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol 25(12):5052\u20135060. doi: 10.1128\/MCB.25.12.5052-5060.2005","journal-title":"Mol Cell Biol"},{"issue":"41","key":"447_CR44","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1038\/sj.onc.1208778","volume":"24","author":"MA Hahn","year":"2005","unstructured":"Hahn MA, Marsh DJ (2005) Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin. Oncogene 24(41):6241\u20136248. doi: 10.1038\/sj.onc.1208778","journal-title":"Oncogene"},{"issue":"8","key":"447_CR45","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.onc.1209893","volume":"26","author":"KJ Bradley","year":"2007","unstructured":"Bradley KJ, Bowl MR, Williams SE, Ahmad BN, Partridge CJ, Patmanidi AL, Kennedy AM, Loh NY, Thakker RV (2007) Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal. Oncogene 26(8):1213\u20131221. doi: 10.1038\/sj.onc.1209893","journal-title":"Oncogene"},{"issue":"2","key":"447_CR46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/1541-7786.MCR-06-0129","volume":"5","author":"L Lin","year":"2007","unstructured":"Lin L, Czapiga M, Nini L, Zhang JH, Simonds WF (2007) Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function. Mol Cancer Res 5(2):183\u2013193. doi: 10.1158\/1541-7786.MCR-06-0129","journal-title":"Mol Cancer Res"},{"issue":"26","key":"447_CR47","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1016\/j.febslet.2007.09.050","volume":"581","author":"MA Hahn","year":"2007","unstructured":"Hahn MA, Marsh DJ (2007) Nucleolar localization of parafibromin is mediated by three nucleolar localization signals. FEBS Lett 581(26):5070\u20135074. doi: 10.1016\/j.febslet.2007.09.050","journal-title":"FEBS Lett"},{"issue":"19","key":"447_CR48","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","volume":"10","author":"MH Tan","year":"2004","unstructured":"Tan MH, Morrison C, Wang P, Yang X, Haven CJ, Zhang C, Zhao P, Tretiakova MS, Korpi-Hyovalti E, Burgess JR, Soo KC, Cheah WK, Cao B, Resau J, Morreau H, Teh BT (2004) Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res Off J Am Assoc Cancer Res 10(19):6629\u20136637","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"2","key":"447_CR49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1677\/erc.1.01058","volume":"13","author":"C Juhlin","year":"2006","unstructured":"Juhlin C, Larsson C, Yakoleva T, Leibiger I, Leibiger B, Alimov A, Weber G, Hoog A, Villablanca A (2006) Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer 13(2):509\u2013523","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"447_CR50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","volume":"14","author":"CC Juhlin","year":"2007","unstructured":"Juhlin CC, Villablanca A, Sandelin K, Haglund F, Nordenstrom J, Forsberg L, Branstrom R, Obara T, Arnold A, Larsson C, Hoog A (2007) Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer 14(2):501\u2013512","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"447_CR51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"Howell VM, Gill A, Clarkson A, Nelson AE, Dunne R, Delbridge LW, Robinson BG, Teh BT, Gimm O, Marsh DJ (2009) Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 94(2):434\u2013441","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"447_CR52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hed.21716","volume":"34","author":"HK Kim","year":"2011","unstructured":"Kim HK, Oh YL, Kim SH, Lee DY, Kang HC, Lee JI, Jang HW, Hur KY, Kim JH, Min YK, Chung JH, Kim SW (2011) Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma. Head Neck 34(2):201\u2013206","journal-title":"Head Neck"},{"issue":"5","key":"447_CR53","first-page":"688","volume":"24","author":"JE Witteveen","year":"2011","unstructured":"Witteveen JE, Hamdy NA, Dekkers OM, Kievit J, van Wezel T, Teh BT, Romijn JA, Morreau H (2011) Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma. Modern Pathol Off J US Can Acad Pathol Inc 24(5):688\u2013697","journal-title":"Modern Pathol Off J US Can Acad Pathol Inc"},{"issue":"9","key":"447_CR54","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/gcc.20895","volume":"50","author":"LF Starker","year":"2011","unstructured":"Starker LF, Svedlund J, Udelsman R, Dralle H, Akerstrom G, Westin G, Lifton RP, Bjorklund P, Carling T (2011) The DNA methylome of benign and malignant parathyroid tumors. Genes Chromosom Cancer 50(9):735\u2013745","journal-title":"Genes Chromosom Cancer"},{"key":"447_CR55","author":"J Costa-Guda","year":"2013","unstructured":"Costa-Guda J, Imanishi Y, Palanisamy N, Kawamata N, Phillip Koeffler H, Chaganti RS, Arnold A (2013) Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins. Endocrine. doi: 10.1007\/s12020-013-9903-4","journal-title":"Endocrine"},{"issue":"4","key":"447_CR56","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s40618-014-0234-y","volume":"38","author":"C Verdelli","year":"2015","unstructured":"Verdelli C, Forno I, Vaira V, Corbetta S (2015) MicroRNA deregulation in parathyroid tumours suggests an embryonic signature. J Endocrinol Invest 38(4):383\u2013388. doi: 10.1007\/s40618-014-0234-y","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"447_CR57","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.pap.0000151319.42376.d4","volume":"12","author":"RA DeLellis","year":"2005","unstructured":"DeLellis RA (2005) Parathyroid carcinoma: an overview. Adv Anat Pathol 12(2):53\u201361 00125480-200503000-00003 [pii]","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"447_CR58","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0","volume":"31","author":"A Schantz","year":"1973","unstructured":"Schantz A, Castleman B (1973) Parathyroid carcinoma. A study of 70 cases. Cancer 31(3):600\u2013605","journal-title":"Cancer"},{"key":"447_CR59","unstructured":"Bondenson L, Grimelius L, DeLellis RA, Lloyd R, Akerstrom G, Larsson C, Arnold A, Eng C, Shane E, Bilezikian JP (2004) Parathyroid carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) Pathology and genetics. Tumors of Endocrine organs. WHO Classification of Tumours. IARC Press, Lyon, pp 124\u2013127"},{"issue":"4","key":"447_CR60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12022-008-9050-2","volume":"19","author":"RA Delellis","year":"2008","unstructured":"Delellis RA (2008) Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma. Endocrine Pathol 19(4):221\u2013225. doi: 10.1007\/s12022-008-9050-2","journal-title":"Endocrine Pathol"},{"key":"447_CR61","first-page":"103","volume-title":"Endocrine pathology","author":"RL Apel","year":"2002","unstructured":"Apel RL (2002) The parathyroid glands. In: LiVolsi VA, Asa SL (eds) Endocrine pathology. Churchill Livingstone, Philadelphia, pp 103\u2013147"},{"issue":"4","key":"447_CR62","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/BF00353773","volume":"18","author":"K Sandelin","year":"1994","unstructured":"Sandelin K, Tullgren O, Farnebo LO (1994) Clinical course of metastatic parathyroid cancer. World J Surg 18(4):594\u2013598","journal-title":"World J Surg"},{"issue":"1","key":"447_CR63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2265.2004.01954.x","volume":"60","author":"F Cetani","year":"2004","unstructured":"Cetani F, Pardi E, Viacava P, Pollina GD, Fanelli G, Picone A, Borsari S, Gazzerro E, Miccoli P, Berti P, Pinchera A, Marcocci C (2004) A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer. Clin Endocrinol 60(1):99\u2013106 (1954 [pii])","journal-title":"Clin Endocrinol"},{"issue":"8","key":"447_CR64","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.humpath.2005.06.020","volume":"36","author":"N Bergero","year":"2005","unstructured":"Bergero N, De Pompa R, Sacerdote C, Gasparri G, Volante M, Bussolati G, Papotti M (2005) Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol 36(8):908\u2013914. doi: 10.1016\/j.humpath.2005.06.020","journal-title":"Hum Pathol"},{"issue":"2","key":"447_CR65","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","volume":"115","author":"GG Fernandez-Ranvier","year":"2009","unstructured":"Fernandez-Ranvier GG, Khanafshar E, Tacha D, Wong M, Kebebew E, Duh QY, Clark OH (2009) Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer 115(2):334\u2013344","journal-title":"Cancer"},{"issue":"16","key":"447_CR66","first-page":"2895","volume":"125","author":"O Wang","year":"2012","unstructured":"Wang O, Wang CY, Shi J, Nie M, Xia WB, Li M, Jiang Y, Guan H, Meng XW, Xing XP (2012) Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors. Chin Med J (Engl) 125(16):2895\u20132901","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"447_CR67","doi-asserted-by":"crossref","first-page":"E478","DOI":"10.1210\/jc.2014-2760","volume":"100","author":"A Shifrin","year":"2015","unstructured":"Shifrin A, LiVolsi V, Shifrin-Douglas S, Zheng M, Erler B, Matulewicz T, Davis J (2015) Primary and metastatic parathyroid malignancies: a rare or underdiagnosed condition? J Clin Endocrinol Metab 100(3):E478\u2013E481. doi: 10.1210\/jc.2014-2760","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"447_CR68","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00000478-199903000-00007","volume":"23","author":"LA Erickson","year":"1999","unstructured":"Erickson LA, Jin L, Wollan P, Thompson GB, van Heerden JA, Lloyd RV (1999) Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. Am J Surg Pathol 23(3):288\u2013295","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"447_CR69","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","volume":"30","author":"AJ Gill","year":"2006","unstructured":"Gill AJ, Clarkson A, Gimm O, Keil J, Dralle H, Howell VM, Marsh DJ (2006) Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol 30(9):1140\u20131149","journal-title":"Am J Surg Pathol"},{"issue":"25","key":"447_CR70","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","volume":"365","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Cetani F (2011) Clinical practice. Primary hyperparathyroidism. N Engl J Med 365(25):2389\u20132397. doi: 10.1056\/NEJMcp1106636","journal-title":"N Engl J Med"},{"issue":"8","key":"447_CR71","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1373\/clinchem.2007.085506","volume":"53","author":"MR Rubin","year":"2007","unstructured":"Rubin MR, Silverberg SJ, D\u2019Amour P, Brossard JH, Rousseau L, Sliney J Jr, Cantor T, Bilezikian JP (2007) An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma. Clin Chem 53(8):1470\u20131476. doi: 10.1373\/clinchem.2007.085506","journal-title":"Clin Chem"},{"issue":"8","key":"447_CR72","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1210\/jc.2009-2791","volume":"95","author":"E Cavalier","year":"2010","unstructured":"Cavalier E, Daly AF, Betea D, Pruteanu-Apetrii PN, Delanaye P, Stubbs P, Bradwell AR, Chapelle JP, Beckers A (2010) The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma. J Clin Endocrinol Metab 95(8):3745\u20133749. doi: 10.1210\/jc.2009-2791","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"447_CR73","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2265.2011.04021.x","volume":"74","author":"P Caron","year":"2011","unstructured":"Caron P, Simonds WF, Maiza JC, Rubin M, Cantor T, Rousseau L, Bilezikian JP, Souberbielle JC, D\u2019Amour P (2011) Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation. Clin Endocrinol 74(6):694\u2013698. doi: 10.1111\/j.1365-2265.2011.04021.x","journal-title":"Clin Endocrinol"},{"issue":"4","key":"447_CR74","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/EJE-08-0169","volume":"159","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Bilezikian JP, Birken S, Silverberg SJ (2008) Human chorionic gonadotropin measurements in parathyroid carcinoma. Eur J Endocrinol\/Eur Feder Endocrine Soc 159(4):469\u2013474. doi: 10.1530\/EJE-08-0169","journal-title":"Eur J Endocrinol\/Eur Feder Endocrine Soc"},{"issue":"8","key":"447_CR75","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1245\/s10434-010-1003-6","volume":"17","author":"N Talat","year":"2010","unstructured":"Talat N, Schulte KM (2010) Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann Surg Oncol 17(8):2156\u20132174. doi: 10.1245\/s10434-010-1003-6","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"447_CR76","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00595-007-3612-7","volume":"38","author":"BA Whitson","year":"2008","unstructured":"Whitson BA, Broadie TA (2008) Preoperative ultrasound and nuclear medicine studies improve the accuracy in localization of adenoma in hyperparathyroidism. Surg Today 38(3):222\u2013226. doi: 10.1007\/s00595-007-3612-7","journal-title":"Surg Today"},{"issue":"1","key":"447_CR77","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ejrad.2012.08.003","volume":"82","author":"JH Kwon","year":"2013","unstructured":"Kwon JH, Kim EK, Lee HS, Moon HJ, Kwak JY (2013) Neck ultrasonography as preoperative localization of primary hyperparathyroidism with an additional role of detecting thyroid malignancy. Eur J Radiol 82(1):e17\u2013e21. doi: 10.1016\/j.ejrad.2012.08.003","journal-title":"Eur J Radiol"},{"issue":"9","key":"447_CR78","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00330-011-2141-3","volume":"21","author":"PS Sidhu","year":"2011","unstructured":"Sidhu PS, Talat N, Patel P, Mulholland NJ, Schulte KM (2011) Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: a retrospective analysis of parathyroid tumours larger than 15\u00a0mm. Eur Radiol 21(9):1865\u20131873. doi: 10.1007\/s00330-011-2141-3","journal-title":"Eur Radiol"},{"issue":"3","key":"447_CR79","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1148\/radiol.12110852","volume":"264","author":"GJ Hunter","year":"2012","unstructured":"Hunter GJ, Schellingerhout D, Vu TH, Perrier ND, Hamberg LM (2012) Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. Radiology 264(3):789\u2013795. doi: 10.1148\/radiol.12110852","journal-title":"Radiology"},{"issue":"10","key":"447_CR80","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5306\/wjco.v2.i10.348","volume":"2","author":"L Evangelista","year":"2011","unstructured":"Evangelista L, Sorgato N, Torresan F, Boschin IM, Pennelli G, Saladini G, Piotto A, Rubello D, Pelizzo MR (2011) FDG-PET\/CT and parathyroid carcinoma: review of literature and illustrative case series. World J Clin Oncol 2(10):348\u2013354. doi: 10.5306\/wjco.v2.i10.348","journal-title":"World J Clin Oncol"},{"issue":"1","key":"447_CR81","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.4081\/rt.2013.e12","volume":"5","author":"ME Allen","year":"2013","unstructured":"Allen ME, Semrad A, Yang AD, Martinez SR (2013) Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring? Rare Tumors 5(1):e12. doi: 10.4081\/rt.2013.e12","journal-title":"Rare Tumors"},{"issue":"8","key":"447_CR82","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hed.20049","volume":"26","author":"NL Busaidy","year":"2004","unstructured":"Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM Jr, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26(8):716\u2013726","journal-title":"Head Neck"},{"issue":"9","key":"447_CR83","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.22599","volume":"109","author":"PK Lee","year":"2007","unstructured":"Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM (2007) Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 109(9):1736\u20131741. doi: 10.1002\/cncr.22599","journal-title":"Cancer"},{"issue":"4","key":"447_CR84","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/BF02067369","volume":"16","author":"K Sandelin","year":"1992","unstructured":"Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO (1992) Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg 16(4):724\u2013731","journal-title":"World J Surg"},{"issue":"3","key":"447_CR85","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K","volume":"86","author":"SA Hundahl","year":"1999","unstructured":"Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the US between 1985\u20131995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86(3):538\u2013544. doi: 10.1002\/(SICI)1097-0142(19990801)86:3<538:AID-CNCR25>3.0.CO;2-K","journal-title":"Cancer"},{"issue":"4","key":"447_CR86","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11864-001-0028-2","volume":"2","author":"E Kebebew","year":"2001","unstructured":"Kebebew E (2001) Parathyroid carcinoma. Curr Treat Options Oncol 2(4):347\u2013354","journal-title":"Curr Treat Options Oncol"},{"issue":"11","key":"447_CR87","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s00268-010-0722-y","volume":"34","author":"KM Schulte","year":"2010","unstructured":"Schulte KM, Talat N, Miell J, Moniz C, Sinha P, Diaz-Cano S (2010) Lymph node involvement and surgical approach in parathyroid cancer. World J Surg 34(11):2611\u20132620. doi: 10.1007\/s00268-010-0722-y","journal-title":"World J Surg"},{"issue":"4","key":"447_CR88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF03343718","volume":"23","author":"C Spinelli","year":"2000","unstructured":"Spinelli C, Bonadio AG, Berti P, Materazzi G, Miccoli P (2000) Cutaneous spreading of parathyroid carcinoma after fine needle aspiration cytology. J Endocrinol Invest 23(4):255\u2013257","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"447_CR89","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/bjs.5182","volume":"92","author":"N Rawat","year":"2005","unstructured":"Rawat N, Khetan N, Williams DW, Baxter JN (2005) Parathyroid carcinoma. Br J Surg 92(11):1345\u20131353. doi: 10.1002\/bjs.5182","journal-title":"Br J Surg"},{"issue":"4","key":"447_CR90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00005792-199207000-00002","volume":"71","author":"AG Wynne","year":"1992","unstructured":"Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA (1992) Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore) 71(4):197\u2013205","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"447_CR91","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/cncr.11819","volume":"98","author":"ND Munson","year":"2003","unstructured":"Munson ND, Foote RL, Northcutt RC, Tiegs RD, Fitzpatrick LA, Grant CS, van Heerden JA, Thompson GB, Lloyd RV (2003) Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer 98(11):2378\u20132384. doi: 10.1002\/cncr.11819","journal-title":"Cancer"},{"issue":"5","key":"447_CR92","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cncr.20089","volume":"100","author":"GL Clayman","year":"2004","unstructured":"Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou-Sellin R (2004) Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer 100(5):900\u2013905. doi: 10.1002\/cncr.20089","journal-title":"Cancer"},{"issue":"24","key":"447_CR93","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1200\/JCO.2007.15.9038","volume":"26","author":"A Artinyan","year":"2008","unstructured":"Artinyan A, Guzman E, Maghami E, Al-Sayed M, D\u2019Apuzzo M, Wagman L, Kim J (2008) Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization. J Clin Oncol 26(24):4039\u20134041. doi: 10.1200\/JCO.2007.15.9038","journal-title":"J Clin Oncol"},{"issue":"3","key":"447_CR94","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00270-009-9730-4","volume":"33","author":"M Tochio","year":"2010","unstructured":"Tochio M, Takaki H, Yamakado K, Uraki J, Kashima M, Nakatsuka A, Takao M, Shimamoto A, Tarukawa T, Shimpo H, Takeda K (2010) A case report of 20 lung radiofrequency ablation sessions for 50 lung metastases from parathyroid carcinoma causing hyperparathyroidism. Cardiovasc Intervent Radiol 33(3):657\u2013659. doi: 10.1007\/s00270-009-9730-4","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"447_CR95","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/hcu166","volume":"108","author":"CV Tong","year":"2015","unstructured":"Tong CV, Hussein Z, Noor NM, Mohamad M, Ng WF (2015) Use of denosumab in parathyroid carcinoma with refractory hypercalcemia. QJM Mon J Assoc Physicians 108(1):49\u201350. doi: 10.1093\/qjmed\/hcu166","journal-title":"QJM Mon J Assoc Physicians"},{"issue":"7","key":"447_CR96","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1210\/jc.2003-031911","volume":"89","author":"D Betea","year":"2004","unstructured":"Betea D, Bradwell AR, Harvey TC, Mead GP, Schmidt-Gayk H, Ghaye B, Daly AF, Beckers A (2004) Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma. J Clin Endocrinol Metab 89(7):3413\u20133420. doi: 10.1210\/jc.2003-031911","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"447_CR97","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1507\/endocrj.K09E-283","volume":"57","author":"I Horie","year":"2010","unstructured":"Horie I, Ando T, Inokuchi N, Mihara Y, Miura S, Imaizumi M, Usa T, Kinoshita N, Sekine I, Kamihara S, Eguchi K (2010) First Japanese patient treated with parathyroid hormone peptide immunization for refractory hypercalcemia caused by metastatic parathyroid carcinoma. Endocr J 57(4):287\u2013292 (JST.JSTAGE\/endocrj\/K09E\u2212283 [pii])","journal-title":"Endocr J"},{"issue":"3","key":"447_CR98","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1530\/eje.0.1420300","volume":"142","author":"M Schott","year":"2000","unstructured":"Schott M, Feldkamp J, Schattenberg D, Krueger T, Dotzenrath C, Seissler J, Scherbaum WA (2000) Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells. Eur J Endocrinol\/Eur Feder Endocrine Soc 142(3):300\u2013306 (1420300 [pii])","journal-title":"Eur J Endocrinol\/Eur Feder Endocrine Soc"},{"issue":"1","key":"447_CR99","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1210\/jc.2010-1221","volume":"96","author":"M Peacock","year":"2011","unstructured":"Peacock M, Bilezikian JP, Bolognese MA, Borofsky M, Scumpia S, Sterling LR, Cheng S, Shoback D (2011) Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity. J Clin Endocrinol Metab 96(1):E9\u2013E18. doi: 10.1210\/jc.2010-1221","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"447_CR100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/cen.12108","volume":"79","author":"F Saponaro","year":"2013","unstructured":"Saponaro F, Faggiano A, Grimaldi F, Borretta G, Brandi ML, Minisola S, Frasoldati A, Papini E, Scillitani A, Banti C, Prete MD, Vescini F, Gianotti L, Cavalli L, Romagnoli E, Colao A, Cetani F, Marcocci C (2013) Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group. Clin Endocrinol 79(1):20\u201326. doi: 10.1111\/cen.12108","journal-title":"Clin Endocrinol"},{"issue":"10","key":"447_CR101","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","volume":"92","author":"SJ Silverberg","year":"2007","unstructured":"Silverberg SJ, Rubin MR, Faiman C, Peacock M, Shoback DM, Smallridge RC, Schwanauer LE, Olson KA, Klassen P, Bilezikian JP (2007) Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 92(10):3803\u20133808. doi: 10.1210\/jc.2007-0585","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0447-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-016-0447-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0447-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:03:45Z","timestamp":1559502225000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-016-0447-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":101,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1007\/s40618-016-0447-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}